From the LSMS Committee on Chronic Diseases. Recent media reports of potential risks from calcium antagonists.
Frohlich
E D
ED
D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D016022:Case-Control Studies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000139:chemically induced / Q000453:epidemiology*; D012307:Risk Factors
D002121:Calcium Channel Blockers